It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Khavandi: Inhaled therapy — viewed as a standard of care — provides symptom relief to patients and can also reduce exacerbation rate. However, more than 40% of patients with COPD continue to ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Chronic obstructive pulmonary disease (COPD) can be treated with lifestyle changes, prescription medications, and specialist ...

EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies. ... the recommended treatment for COPD in Europe is an inhaled corticosteroid (ICS), ...